Robert B Jones - Net Worth and Insider Trading
Robert B Jones Net Worth
The estimated net worth of Robert B Jones is at least $619 dollars as of 2024-11-05. Robert B Jones is the President and CEO of Acura Pharmaceuticals Inc and owns about 412,555 shares of Acura Pharmaceuticals Inc (ACUR) stock worth over $619. Details can be seen in Robert B Jones's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert B Jones has not made any transactions after 2017-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert B Jones
Robert B Jones Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert B Jones owns 1 companies in total, including Acura Pharmaceuticals Inc (ACUR) .
Click here to see the complete history of Robert B Jones’s form 4 insider trades.
Insider Ownership Summary of Robert B Jones
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ACUR | Acura Pharmaceuticals Inc | 2020-01-02 | President & CEO |
Robert B Jones Latest Holdings Summary
Robert B Jones currently owns a total of 1 stock. Robert B Jones owns 412,555 shares of Acura Pharmaceuticals Inc (ACUR) as of December 14, 2017, with a value of $619.
Latest Holdings of Robert B Jones
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ACUR | Acura Pharmaceuticals Inc | 2017-12-14 | 412,555 | 0.00 | 619 |
Holding Weightings of Robert B Jones
Robert B Jones Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert B Jones has made a total of 0 transactions in Acura Pharmaceuticals Inc (ACUR) over the past 5 years. The most-recent trade in Acura Pharmaceuticals Inc is the acquisition of 400,000 shares on December 14, 2017, which cost Robert B Jones around $40,000.
Insider Trading History of Robert B Jones
- 1
Robert B Jones Trading Performance
GuruFocus tracks the stock performance after each of Robert B Jones's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert B Jones is 67.65%. GuruFocus also compares Robert B Jones's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert B Jones within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert B Jones's insider trading performs compared to the benchmark.
Performance of Robert B Jones
Robert B Jones Ownership Network
Ownership Network List of Robert B Jones
Ownership Network Relation of Robert B Jones
Robert B Jones Owned Company Details
What does Acura Pharmaceuticals Inc do?
Who are the key executives at Acura Pharmaceuticals Inc?
Robert B Jones is the President & CEO of Acura Pharmaceuticals Inc. Other key executives at Acura Pharmaceuticals Inc include VP & Corporate Development James F Emigh , VP & Treasurer & Controller Robert A Seiser , and VP Pharmaceutical Sciences APT Albert W Brzeczko .
Acura Pharmaceuticals Inc (ACUR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acura Pharmaceuticals Inc (ACUR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acura Pharmaceuticals Inc (ACUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acura Pharmaceuticals Inc (ACUR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acura Pharmaceuticals Inc Insider Transactions
Robert B Jones Mailing Address
Above is the net worth, insider trading, and ownership report for Robert B Jones. You might contact Robert B Jones via mailing address: C/o Acura Pharmaceuticals, Inc. 616 N North Court Palatine Il 60067.